Shares of Nutriband Inc. (NASDAQ:NTRBW – Get Free Report) shot up 17.4% on Wednesday . The stock traded as high as $1.35 and last traded at $1.35. 205 shares traded hands during mid-day trading, a decline of 97% from the average session volume of 7,506 shares. The stock had previously closed at $1.15.
Nutriband Price Performance
The firm’s fifty day moving average is $1.23 and its two-hundred day moving average is $1.11.
About Nutriband
Nutriband Inc develops a portfolio of transdermal pharmaceutical products. Its lead product in development is AVERSA fentanyl, an abuse deterrent fentanyl transdermal system that provides clinicians and patients with an extended-release transdermal fentanyl product for use in managing chronic pain requiring around the clock opioid therapy.
Featured Articles
- Five stocks we like better than Nutriband
- Market Cap Calculator: How to Calculate Market Cap
- Texas Roadhouse Stock Steering for New Highs This Year
- Where to Find Earnings Call Transcripts
- Monopar Therapeutics Skyrockets 400% on Licensing Deal
- Special Purpose Acquisition Company (SPAC) What You Need to Know
- Tractor Supply Stock Pulls Back: A Prime Buying Opportunity
Receive News & Ratings for Nutriband Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nutriband and related companies with MarketBeat.com's FREE daily email newsletter.
